Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Abu Dhabi Investment Authority is the direct owner of 517,241 of the shares of Class A Common Stock represented herein. (2) The percent calculation is based on 811,418,179 shares of Class A Common Stock outstanding as of December 18, 2025 as reported in Medline Inc.'s prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on December 18, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Platinum Falcon B 2018 RSC Limited ("Platinum Falcon") is the direct owner of 46,998,036 of the shares of Class A Common Stock reported herein. Platinum Falcon is a wholly owned subsidiary of Abu Dhabi Investment Authority. Pursuant to the rules and regulations of the Securities and Exchange Commission, Abu Dhabi Investment Authority may be deemed to be the beneficial owner of the shares of Class A Common Stock directly held by Platinum Falcon. (2) The percent calculation based on 811,418,179 shares of Class A Common Stock outstanding as of December 18, 2025 as reported in Medline Inc.'s prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on December 18, 2025.


SCHEDULE 13G



 
Abu Dhabi Investment Authority
 
Signature:/s/ Saif Surour Omair Maaded AlMashghouni
Name/Title:Saif Surour Omair Maaded AlMashghouni/Authorized Signatory
Date:02/11/2026
 
Signature:/s/ Ahmed Salem Abdulla Melaih AlNeyadi
Name/Title:Ahmed Salem Abdulla Melaih AlNeyadi/Authorized Signatory
Date:02/11/2026
 
Platinum Falcon B 2018 RSC Limited
 
Signature:/s/ Saif Surour Omair Maaded AlMashghouni
Name/Title:Saif Surour Omair Maaded AlMashghouni/Authorized Signatory
Date:02/11/2026
 
Signature:/s/ Ahmed Salem Abdulla Melaih AlNeyadi
Name/Title:Ahmed Salem Abdulla Melaih AlNeyadi/Authorized Signatory
Date:02/11/2026
Exhibit Information

Exhibit 1: Joint Filing Agreement

 

Exhibit 1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A Common Stock, par value $0.0001 per share of Medline Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned hereby execute this Agreement.

 

Dated: February 11, 2026

 

  Abu Dhabi Investment Authority
     
  By: /s/ Saif Surour Omair Maaded AlMashghouni
  Name:  Saif Surour Omair Maaded AlMashghouni
  Title: Authorized Signatory
     
  By: /s/ Ahmed Salem Abdulla Melaih AlNeyadi
  Name:  Ahmed Salem Abdulla Melaih AlNeyadi
  Title: Authorized Signatory
     
     
  Platinum Falcon B 2018 RSC Limited
     
  By: /s/ Saif Surour Omair Maaded AlMashghouni
  Name:  Saif Surour Omair Maaded AlMashghouni
  Title: Authorized Signatory
     
  By: /s/ Ahmed Salem Abdulla Melaih AlNeyadi
  Name:  Ahmed Salem Abdulla Melaih AlNeyadi
  Title: Authorized Signatory